Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's good that they are back to the pre-halt status. It means that the problems they found have been dealt with.
Nope, it's still 10M + 100M shares, like it was before the last change were 10M shares disappeared.
I think that this stock must get rids of convertibles and then move to the amex. I think that next year by this time a lot of things will be more clear about the future of this company. Convertibles must be payed in May 2008, revenues from LifeStem should pur in starting in the next 2 quarters.
It means that now we are back to the previous values again.
Nope, not an additional 290M, a total of 290M.
They already have low debts compared to most other penny stock, but their convertible debentures were rather short term (just 3 years). As soon as they'll make revenues from LifeStem they'll be debts free in about a year. I think that they thought they could have repayed their convertibles with their revenues but they have been a year late with LifeStem deployment.
They should issue up to 290M shares to liquidate convertibles.
Anyway they cannot pass the 200M mark for now, at least until they set up a proxy vote do increase the AS over 200M.
Each time they are selling shares they are raising from 100K to 150K$, they already raised more than 400K$.
A reverse split. It happens with stock trading at 0.0001
No one is thinking about a RS! A RS happens when a stock reach 0.0001, and for CLBE to reach 0.0001 their market cap should be of about 15K$, which is impossible (an otcbb reporting shell is valued at 500K$, plus CLBE has 500K$ in assets).
Moreover, CLBE has debts (which are being converted by now, hence the large sales), but they are fairly low compared to every other otc stock out there. Just check the balance sheet.
The daily RSI at 18, never saw a so low value...
With a little buy pressure this will fly. But to get buy pressure they must do something.
It's typical MM games when they are running out of shares on this low floaters nano cap. It's a good sign that the bottom is near this level.
Yes no one in the otc investors community cares about a real company. They only care about pump and dumps.
Nice news again today, too!
CalbaTech Subsidiary Soon to Begin Nation's First Multiple Source Collection of Adult Stem Cells for Future Therapeutic Use
Wednesday October 10, 8:47 am ET
LAGUNA HILLS, Calif., Oct. 10 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE - News), an emerging life sciences company (http://www.CalbaTech.com ) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions, today said that LifeStem(TM) Inc. CEO and Chief Medical Officer Dr. Jason R. Van Tassel has successfully completed training the owners and Chief Medical Office of the Youthtopia Med Spa, a state-of-the-art medical spa in Alpharetta, Georgia, a suburb of Atlanta.
ADVERTISEMENT
When blood and adipose tissue are collected from a client within the next 30 days, it will mark the first time in the U.S. that adult stem cells have been harvested from both sources for future medical use. LifeStem's Stem Cell Microbank(TM) Service is expected to be offered in other spas in other states soon.
LifeStem(TM) is a wholly-owned subsidiary of CalbaTech. The unique process it developed allows for the collection of adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client for medical purposes. LifeStem(TM) also trained the staff on selling techniques.
"Four people were given contracts for immediate service with others expected to follow soon after," said James DeOlden, CalbaTech CEO. "It makes sense to bank adult stem cells while the person is healthy for possible future medical use, with possible therapies ranging from heart disease to diabetes and other medical issues that are currently difficult to treat."
2 years ago the OS was only 25M shares. They diluted to 50M in the first year, then to 90M in the the 1Q 2006, then slowly to 125M in the 4Q 2006 (at the beginning of this year), and finally to I strongly believe to 150M this month. Anyway the price went down a lot more than the dilution and the market cap dropped to ridiculous levels. If they could get the net income to 1M$ a quarter, the right market cap for this would become 1Mx4x20=80M$, ie. 0.5$ a share with the current OS. Once they get to a 1M$ net income it won't be so hard to repay for their accumulated debts too.
Did Kip made money from last run? Nope.
Did Kip told us false and misleading informations? Nope.
A clean pink shell is worth at least 250K$, so 0.01 is the right price for a shell. Of course I really hoped that the name change would imply that the awaited RM happened, but anyway I bought this as a shell and not as a new company.
Like with every shell, money put here is dead money until something happens. But that's the shall game after all.
Fooled by whom and screwed by whom?
It held pretty well yesterday's gains with a decent volume. There's a little wall at 0.017 - 0.018: if this passes it with volumes like today, the next trading level would be in the 0.018-0.025 range. Then the new wall would be at 0.028-0.03, with a third one at 0.037-0.04.
If they are able to release good news in the next months (with a decent 10Q) then we may pass a couple of walls and get this back into decent trading levels.
A whole new story would begin when they will start a revenue stream from LifeStem, TherapyStem and MyStem. If they could only post a 1M net income by March this could still fly towards dimeland.
I received my dividend restricted shares from HVLN (they look like HVLNZZ in my portfolio). Of course they will not be worth nothing when I'll be able to sell them. I sold my HVLN shares some time ago so they at least kept their words with the ex-dividend date.
Yes, with a little more attention we could get to the right level for this stock. The attention on this is so low that I had to post the news myself last week on the OTCBB Alerts board!
But you are talking about a news of the prior company 10 years ago! It was clear that it became a shell after that.
Doesn't look that way to me opening your link.
I already averaged down from my accumulation point at 0.044 down to 0.03
I really hope this will run sooner rather than later. I'm in at an 0.03 average, which still looks pretty cheap to me from a market cap pow but it's really high seing how it has been trading lately. Anyway a 6x to 10x run from here may not be impossible.
But we are on the grey or we are halted? Because if we are on the grey and the deal is off then we'll be here forever.
The chart needs a confirmation but it's looking good. Of course the potential of this stock is much more than what the chart says... I think that this company at least deserves a 10M market cap (which is 0.08 a share) but it does seem that people is still not interested in this stock... there are scams with hundreds of boardmarks and shell stocks with more boardmarks than this, anyway I see that something is changing for the better.
Yes.
That's true what you say. But what about the CPA that is now listed for the company? It's very strange a Pink with a CPA listed for it.
22% of Institutional ownership, wow!
http://moneycentral.msn.com/ownership?Symbol=clbe
There's no only Kip, plus now there's a CPA listed (strange for a Pink) and a lawyer.
The price didn't spike because the volume is low (so they aren't diluting anything now).
The problem with this stock is that otc investors prefer fluffy and frequents prs on pumps and dumps to solid prs.
CLBE (0.01) Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
Thursday October 4, 8:00 am ET
LAGUNA HILLS, Calif., Oct. 4 /PRNewswire-FirstCall/-- CalbaTech, Inc. (OTC Bulletin Board: CLBE - News), an emerging life sciences company (http://www.CalbaTech.com) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions, today announced a corporate update.
LifeStem(TM), Inc., a CalbaTech wholly-owned subsidiary that has developed a unique process to harvest adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client for medical purposes, will be in Atlanta, Georgia this week to train employees of a medspa that will begin selling the Stem Cell Microbank(TM) Service in its Atlanta location. Pre-marketing of the service in the "Atlanta Life" magazine has, according to the owner of the spa, resulted in significant interest by potential clients. LifeStem(TM) will be training the staff in both selling and harvesting techniques.
TherapyStem, Inc., a wholly-owned subsidiary of CalbaTech, signed an MOU with Australian-based Benitec Limited, in which TherapyStem will develop a business providing stem cell storage services for U.S. HIV patients who may use the blood-based stem cells in a possible therapy. Benitec has collaborated with City of Hope, Duarte, California, a biomedical research and treatment center, in the development of a possible HIV therapeutic. This investigational HIV therapeutic creates the possibility that re-engineered blood-based stem cells may be able to take the place of anti-retroviral medication. TherapyStem, Inc. has filed for patent protection for its process to harvest stem cells from HIV infected individuals to be cryopreserved for future transplantation.
MyStem, Inc., a developing wholly-owned subsidiary of CalbaTech, is working to build a platform in which it will sell LifeStem's Stem Cell Microbank(TM) Service into the United Kingdom. One of CalbaTech's founders is working in London developing the licensure and contacts necessary to bring this new subsidiary to market. CalbaTech has also contracted with a group experienced in foreign stock exchange listings to help in listing MyStem on PLUS, a division of the London Stock Exchange.
CalbaTech is in discussions with two medical doctors from Harvard that own a patent that could create another potential cell collection business that would add value to CalbaTech's other services. CalbaTech has submitted a proposal for an exclusive license to this technology. No further information is being provided at this time due to the sensitive nature of the discussions, but CalbaTech will update its shareholders when appropriate.
KD Medical, Inc., http://www.kdmedical.com and Molecula, Inc., http://www.molecula.com , two other wholly-owned subsidiaries of CalbaTech, have overcome the hurdles related to moving their offices last year and have been able to focus on finding new customers for their products.
Both CalbaTech and LifeStem have new offices. CalbaTech is now located at 23341 Del Lago Drive, Laguna Hills, CA, and LifeStem is now in Anaheim, CA. The phone numbers for both companies remain the same, (949) 450-9910 for CalbaTech and (949) 450-9938 for LifeStem. LifeStem's website remains http://www.life-stem.com.
Lastly, CalbaTech is working on creating a new and updated website. It will retain the same address: http://www.calbatech.com. The Company expects to have this website available to shareholders and potential investors in the very near future.
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE - News) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.
Interesting, so they have a CPA too, that's strange for a pink...
Btw, I cannot call since I'm in Europe.
I don't think he is a short, but simply fed up with the company. This stock is falling simply because the little penny stock investors are not buying it anymore because of its behaviour, and bigger players don't even know the existence of this company because they are not promoting themselves enough nor talk to the investors (which is a shame).
This is trading now at the level of a shell company doing nothing and this is a shame on management.
This is a reporting company, not a pink, so the AS is a public number (200M) and if they want to increase it they must request a proxy vote to all shareholders and then file the new number to the SEC.
The merger will not happen until a form S4 will be filed, period. The news have no official value at all.
I had the 5000 shares restriction from the beginning so I could never sell my SOMPF shares. My EQBM investment resulted in a complete loss as of now.
Yes, that's nearly 180K$ rised by DOMS in the last days.
If it's the company diluting (instead of some debts getting converted) I wander what they are doing with that money.
Makes not sense the whole dissolution...
Of course this has not been what everyone was hoping for this play, but most importantly it's really stupid what they are doing: I really don't understand what they are gaining from this move.
I read this on another board. Apparently 350K$+ will be divided by 550M shares, so shareholders will get something like 0.0007 per share.
This is a very strange move, since it will cost them more to dissolute the company than to keep it as a shell on the pinks.
Another, "damn it" write off pink at best!
This is not a pink.